About KindredBio
KindredBio is a company based in Burlingame (United States) founded in 2012 was acquired by Elanco in June 2021.. KindredBio has raised $6.9 million across 3 funding rounds from investors including Elanco and SLR Investment Corp. The company has 64 employees as of December 31, 2022. KindredBio operates in a competitive market with competitors including Zoetis, Ceva, PetMedix, QBiotics and Hester Biosciences, among others.
- Headquarter Burlingame, United States
- Employees 64 as on 31 Dec, 2022
- Stage Public
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Kindred Biosciences, Inc.
-
Annual Revenue
$42.16 M891as on Dec 31, 2020
-
Net Profit
$-21.8 M64as on Dec 31, 2020
-
EBITDA
$-19.97 M68as on Dec 31, 2020
-
Total Equity Funding
$6.9 M (USD)
in 3 rounds
-
Latest Funding Round
$50 M (USD), Debt – Conventional
Oct 02, 2019
-
Investors
Elanco
& 1 more
-
Employee Count
64
as on Dec 31, 2022
-
Acquired by
Elanco
(Jun 16, 2021)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Unlock access to complete
Unlock access to complete
Software Development Team
206 people
Leadership Team
81 people
Sales and Marketing
63 people
Finance and Accounting
48 people
Human Resources and Administration
37 people
Senior Team
31 people
Legal and Compliance
23 people
Product Management Team
23 people
Unlock access to complete
Funding Insights of KindredBio
KindredBio has successfully raised a total of $6.9M across 3 strategic funding rounds. The most recent funding activity was a Debt – Conventional round of $50 million completed in October 2019. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 3
- Last Round Debt – Conventional — $50.0M
-
First Round
First Round
(19 Nov 2012)
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct, 2019 | Amount | Debt – Conventional - KindredBio | Valuation |
investors |
|
| Sep, 2013 | Amount | Series A - KindredBio | Valuation |
investors |
|
| Nov, 2012 | Amount | Seed - KindredBio | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in KindredBio
KindredBio has secured backing from 2 investors, including venture fund and institutional investors. Prominent investors backing the company include Elanco and SLR Investment Corp. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Debt and equity investments are offered by the firm.
|
Founded Year | Domain | Location | |
|
Veterinary food and medicines products are provided for animal health.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by KindredBio
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - KindredBio
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Kindredbio Comparisons
Competitors of KindredBio
KindredBio operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Zoetis, Ceva, PetMedix, QBiotics and Hester Biosciences, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Animal medicines, vaccines, and diagnostics are manufactured and supplied.
|
|
| domain | founded_year | HQ Location |
Animal health therapeutics are developed and supplied globally by Ceva.
|
|
| domain | founded_year | HQ Location |
Developer of monoclonal antibody therapeutics for pets
|
|
| domain | founded_year | HQ Location |
Small molecules from plant extracts are developed for medical applications.
|
|
| domain | founded_year | HQ Location |
Manufacturer of animal vaccines and healthcare products
|
|
| domain | founded_year | HQ Location |
Biopharmaceuticals for animals are manufactured and supplied through partnerships.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Kindredbio
Frequently Asked Questions about KindredBio
When was KindredBio founded?
KindredBio was founded in 2012.
Where is KindredBio located?
KindredBio is headquartered in Burlingame, United States. It is registered at Burlingame, California, United States.
Is KindredBio a funded company?
KindredBio is a funded company, having raised a total of $6.9M across 3 funding rounds to date. The company's 1st funding round was a Seed of $1M, raised on Nov 19, 2012.
How many employees does KindredBio have?
As of Dec 31, 2022, the latest employee count at KindredBio is 64.
What is the annual revenue of KindredBio?
Annual revenue of KindredBio is $42.16M as on Dec 31, 2020.
What does KindredBio do?
Kindred Biosciences was founded in 2012 and is headquartered in Burlingame, United States. Operations are centered on veterinary biotechnology, with a focus on antibody-based therapies for animal diseases. Treatments targeting conditions in cats, dogs, and horses have been developed by the company. Activities encompass research and development within the animal health sector, supporting therapeutic advancements for companion and equine species.
Who are the top competitors of KindredBio?
Who are KindredBio's investors?
KindredBio has 2 investors. Key investors include Elanco, and SLR Investment Corp.